Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Centre hospitalier de l'Université de Montréal (CHUM)
Pusan National University Hospital
University of California, Davis
University Hospital Heidelberg
Abramson Cancer Center at Penn Medicine
M.D. Anderson Cancer Center
Carevive Systems, Inc.
University of Pennsylvania
City of Hope Medical Center
VA Office of Research and Development
Ohio State University Comprehensive Cancer Center
Royal North Shore Hospital
Ohio State University Comprehensive Cancer Center
Dana-Farber Cancer Institute
City of Hope Medical Center
Wake Forest University Health Sciences
Abramson Cancer Center at Penn Medicine
Institut universitaire de cardiologie et de pneumologie de Québec, University Laval
University of California, Irvine
Wake Forest University Health Sciences
Fred Hutchinson Cancer Center
Kaiser Permanente
University of Colorado, Denver
Istanbul University
Varian, a Siemens Healthineers Company
Complement Theory Inc.
City of Hope Medical Center
UNICANCER
University of Utah
Hasan Kalyoncu University
City of Hope Medical Center
M.D. Anderson Cancer Center
Hannover Medical School
Tufts University
Ohio State University Comprehensive Cancer Center
OHSU Knight Cancer Institute
Intuitive Surgical
Washington University School of Medicine
Milton S. Hershey Medical Center
University of Utah
University of Arkansas
Hacettepe University
Groupe Hospitalier de la Region de Mulhouse et Sud Alsace
Memorial Sloan Kettering Cancer Center
Instituto Nacional de Cancerologia de Mexico
Noah Medical
Odense University Hospital
Memorial Sloan Kettering Cancer Center
Azienda USL Reggio Emilia - IRCCS